specific applications
as defined in Directive 2001/83/EC of the European Parliament and of the Council of…
Part II provides derogation for ‘Specific applications’, i.e. well-established medicinal use, essentially similar products, fixed combinations, similar biological products, exceptional circumstances and mixed applications (part bibliographic and part own studies).